AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous …
Biotechnology
US, Menlo Park [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
AN2 Therapeutics, Inc. has no acquisition track records yet.
M&A Deals · History
AN2 Therapeutics, Inc. has no acquisition track records yet.